Assessing acute colitis induced by dextran sulfate sodium in rats and its impact on gastrointestinal fluids

[1]  Y. Lim,et al.  Oxyresveratrol Ameliorates Dextran Sulfate Sodium-Induced Colitis in Rats by Suppressing Inflammation , 2021, Molecules.

[2]  Jiande D. Z. Chen,et al.  Transitional changes in gastrointestinal transit and rectal sensitivity from active to recovery of inflammation in a rodent model of colitis , 2021, Scientific Reports.

[3]  A. Stallmach,et al.  An Update for Pharmacologists on New Treatment Options for Inflammatory Bowel Disease: The Clinicians’ Perspective , 2021, Frontiers in Pharmacology.

[4]  A. Day,et al.  An Overview of Tools to Score Severity in Pediatric Inflammatory Bowel Disease , 2021, Frontiers in Pediatrics.

[5]  Christel A. S. Bergström,et al.  Proteomics-informed identification of luminal targets for in situ diagnosis of inflammatory bowel disease. , 2020, Journal of pharmaceutical sciences.

[6]  H. Itoh,et al.  Circulating S100A8/A9 is potentially a biomarker that could reflect the severity of experimental colitis in rats , 2020, Heliyon.

[7]  L. Stassen,et al.  ECCO Guidelines on Therapeutics in Crohn's Disease: medical treatment. , 2019, Journal of Crohn's & colitis.

[8]  Mohamed A. K. Basuony,et al.  Telmisartan ameliorates dextran sodium sulfate-induced colitis in rats by modulating NF-κB signalling in the context of PPARγ agonistic activity. , 2019, Archives of biochemistry and biophysics.

[9]  A. Müllertz,et al.  Developing a predictive in vitro dissolution model based on gastrointestinal fluid characterisation in rats. , 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[10]  J. Frank,et al.  Therapeutic ultrasound attenuates DSS-induced colitis through the cholinergic anti-inflammatory pathway , 2019, EBioMedicine.

[11]  S. Vermeire,et al.  New biologics and small molecules in inflammatory bowel disease: an update , 2019, Therapeutic advances in gastroenterology.

[12]  S. Devaraj,et al.  Anti-inflammatory activity of Alpinia officinarum hance on rat colon inflammation and tissue damage in DSS induced acute and chronic colitis models , 2018, Food Science and Human Wellness.

[13]  T. Tomita,et al.  Association between gastrointestinal motility and macrophage/mast cell distribution in mice during the healing stage after DSS-induced colitis , 2018, Molecular medicine reports.

[14]  K. Katsanos,et al.  Role of bile acids in inflammatory bowel disease , 2018, Annals of gastroenterology.

[15]  Kung-I Feng,et al.  Effect of composition of simulated intestinal media on the solubility of poorly soluble compounds investigated by design of experiments , 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[16]  C. Lehr,et al.  Targeted delivery of Cyclosporine A by polymeric nanocarriers improves the therapy of inflammatory bowel disease in a relevant mouse model , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[17]  K. Kharbanda,et al.  Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis , 2017, World journal of gastroenterology.

[18]  C. Langner,et al.  Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. , 2017, Journal of Crohn's & colitis.

[19]  H. Tilg,et al.  Lipocalin-2: A Master Mediator of Intestinal and Metabolic Inflammation , 2017, Trends in Endocrinology & Metabolism.

[20]  T. Molnár,et al.  Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management. , 2017, Journal of Crohn's & colitis.

[21]  A Müllertz,et al.  In Vivo Precipitation of Poorly Soluble Drugs from Lipid-Based Drug Delivery Systems. , 2016, Molecular pharmaceutics.

[22]  P. Blier,et al.  MAG-EPA reduces severity of DSS-induced colitis in rats. , 2016, American journal of physiology. Gastrointestinal and liver physiology.

[23]  J. Clarke,et al.  Housing experimental rats in solid-based cages with digestible bedding may confound outcomes of nutritional studies. , 2015, Journal of the science of food and agriculture.

[24]  J. Dressman,et al.  Composition and physicochemical properties of fasted-state human duodenal and jejunal fluid: a critical evaluation of the available data. , 2014, Journal of pharmaceutical sciences.

[25]  A. Müllertz,et al.  Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations, Part 6: Effects of Varying Pancreatin and Calcium Levels , 2014, The AAPS Journal.

[26]  C. Pouton,et al.  An in vitro digestion test that reflects rat intestinal conditions to probe the importance of formulation digestion vs first pass metabolism in Danazol bioavailability from lipid based formulations. , 2014, Molecular pharmaceutics.

[27]  Mark McAllister,et al.  Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[28]  B. Chassaing,et al.  Dextran Sulfate Sodium (DSS)‐Induced Colitis in Mice , 2014, Current protocols in immunology.

[29]  V. Préat,et al.  Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis. , 2013, International journal of pharmaceutics.

[30]  A. Müllertz,et al.  Bile salts and their importance for drug absorption. , 2013, International journal of pharmaceutics.

[31]  Shyamasree Ghosh,et al.  C-reactive protein and the biology of disease , 2013, Immunologic Research.

[32]  A. Young,et al.  Fecal Lipocalin 2, a Sensitive and Broadly Dynamic Non-Invasive Biomarker for Intestinal Inflammation , 2012, PloS one.

[33]  Yutao Yan,et al.  Dextran Sodium Sulfate (DSS) Induces Colitis in Mice by Forming Nano-Lipocomplexes with Medium-Chain-Length Fatty Acids in the Colon , 2012, PloS one.

[34]  J. Lewis.  The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease. , 2011, Gastroenterology.

[35]  I. Cuthill,et al.  Animal Research: Reporting In Vivo Experiments: The ARRIVE Guidelines , 2010, British journal of pharmacology.

[36]  J. Dressman,et al.  Characterization of the Ascending Colon Fluids in Ulcerative Colitis , 2010, Pharmaceutical Research.

[37]  G. Dalmasso,et al.  Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model. , 2010, Gastroenterology.

[38]  T. Langmann,et al.  Serum bile acid profiling reflects enterohepatic detoxification state and intestinal barrier function in inflammatory bowel disease. , 2009, World journal of gastroenterology.

[39]  Christos Reppas,et al.  Characterization of the Contents of Ascending Colon to Which Drugs are Exposed After Oral Administration to Healthy Adults , 2009, Pharmaceutical Research.

[40]  H. Takeuchi,et al.  pH-Sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[41]  M. Geier,et al.  Small-Intestinal Manifestations of Dextran Sulfate Sodium Consumption in Rats and Assessment of the Effects of Lactobacillus fermentum BR11 , 2009, Digestive Diseases and Sciences.

[42]  J. Jahnsen,et al.  C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study , 2008, Gut.

[43]  W. Koltun,et al.  Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis. , 2007, The Journal of surgical research.

[44]  Stefan Wirtz,et al.  Chemically induced mouse models of intestinal inflammation , 2007, Nature Protocols.

[45]  Makoto Kataoka,et al.  Site of drug absorption after oral administration: assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[46]  Takuji Tanaka,et al.  Dextran sodium sulfate strongly promotes colorectal carcinogenesis in ApcMin/+ mice: Inflammatory stimuli by dextran sodium sulfate results in development of multiple colonic neoplasms , 2006, International journal of cancer.

[47]  K. Hatakeyama,et al.  Multipotential acceptance of Peyer's patches in the intestine for both thymus‐derived T cells and extrathymic T cells in mice , 2005, Immunology and cell biology.

[48]  Y. Kawashima,et al.  A pH-sensitive microsphere system for the colon delivery of tacrolimus containing nanoparticles. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[49]  S. Poulsen,et al.  Luminal and parenteral TFF2 and TFF3 dimer and monomer in two models of experimental colitis in the rat , 2005, Regulatory Peptides.

[50]  C. Hack,et al.  Rat C‐reactive protein activates the autologous complement system , 2003, Immunology.

[51]  M. Grisham,et al.  Role of appendix and spleen in experimental colitis. , 2001, The Journal of surgical research.

[52]  D. Rampton,et al.  Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs , 2001, Gut.

[53]  R. Verger,et al.  The specific activities of human digestive lipases measured from the in vivo and in vitro lipolysis of test meals. , 2000, Gastroenterology.

[54]  Press,et al.  Gastrointestinal pH profiles in patients with inflammatory bowel disease , 1998, Alimentary pharmacology & therapeutics.

[55]  C. Elson,et al.  Experimental models of inflammatory bowel disease. , 1995, Gastroenterology.

[56]  R. Gore.  Colonic contour changes in chronic ulcerative colitis: reappraisal of some old concepts. , 1992, AJR. American journal of roentgenology.

[57]  M. Hamosh,et al.  Lingual and gastric lipases: species differences in the origin of prepancreatic digestive lipases and in the localization of gastric lipase. , 1988, Biochimica et biophysica acta.

[58]  M. Coates,et al.  Gastrointestinal pH measurement in rats: influence of the microbial flora, diet and fasting , 1987, Laboratory animals.

[59]  J. Tanner,et al.  Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. I. , 1966, Archives of disease in childhood.

[60]  H. Smith,et al.  OBSERVATIONS ON THE FLORA OF THE ALIMENTARY TRACT OF ANIMALS AND FACTORS AFFECTING ITS COMPOSITION. , 1965, The Journal of pathology and bacteriology.